OI
CME icon

Oakbrook Investments’s CME Group CME Stock Holding History

Oakbrook Investments’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$344K Sell
1,992
-5,483
-73% -$1.09M 0.88% 44
2019
Q4 		$1.5M Sell
7,475
-189,616
-96% -$38.9M 0.31% 58
2019
Q3 		$41.7M Sell
197,091
-119
-0.1% -$24.9K 2.71% 6
2019
Q2 		$38.3M Sell
197,210
-9,750
-5% -$1.8M 2.3% 10
2019
Q1 		$34.1M Sell
206,960
-90
-0% -$15.9K 2.07% 12
2018
Q4 		$39M Sell
207,050
-1,515
-0.7% -$280K 2.64% 2
2018
Q3 		$35.5M Sell
208,565
-12,433
-6% -$2.09M 1.97% 10
2018
Q2 		$36.2M Sell
220,998
-110
-0% -$18K 2.29% 12
2018
Q1 		$35.8M Sell
221,108
-10,930
-5% -$1.74M 2.22% 10
2017
Q4 		$33.9M Buy
232,038
+10,620
+5% +$1.51M 2.15% 10
2017
Q3 		$30M Sell
221,418
-7
-0% -$884 1.94% 13
2017
Q2 		$27.7M Buy
221,425
+1,780
+0.8% +$213K 1.84% 13
2017
Q1 		$26.1M Sell
219,645
-8,070
-4% -$971K 1.7% 13
2016
Q4 		$26.3M Buy
227,715
+8,310
+4% +$925K 1.72% 15
2016
Q3 		$22.9M Sell
219,405
-72,885
-25% -$7.61M 1.4% 19
2016
Q2 		$28.5M Buy
292,290
+83,200
+40% +$7.86M 1.58% 12
2016
Q1 		$20.1M Sell
209,090
-2,515
-1% -$229K 1.29% 19
2015
Q4 		$19.2M Buy
211,605
+15,020
+8% +$1.41M 1.22% 19
2015
Q3 		$18.2M Sell
196,585
-1,300
-0.7% -$124K 1.2% 18
2015
Q2 		$18.4M Buy
197,885
+1,115
+0.6% +$104K 1.12% 20
2015
Q1 		$18.6M Sell
196,770
-24,395
-11% -$2.26M 1.01% 23
2014
Q4 		$19.6M Buy
221,165
+24,255
+12% +$2.06M 1.06% 26
2014
Q3 		$15.7M Sell
196,910
-105,350
-35% -$7.94M 0.85% 34
2014
Q2 		$21.4M Buy
302,260
+104,025
+52% +$7.32M 0.65% 39
2014
Q1 		$14.7M Sell
198,235
-62,085
-24% -$4.68M 0.46% 54
2013
Q4 		$20.4M Sell
260,320
-7,120
-3% -$557K 0.57% 46
2013
Q3 		$19.8M Sell
267,440
-66,420
-20% -$4.89M 0.58% 46
2013
Q2 		$25.4M Buy
+333,860
New +$21.9M 0.73% 31

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Oakbrook Investments's CME Position: Q1 2020 in Review

Oakbrook Investments reduced its CME Group (CME) stake by 73% in Q1 2020, selling an estimated $1.09M and leaving 1,992 shares worth $344K. The position accounts for 0.88% of the portfolio, ranked #44.

Oakbrook Investments first reported a position in CME in Q2 2013 and has held it in 28 quarters since. The position peaked at $41.7M in Q3 2019. 1,030 funds tracked by Wall St. Rank hold CME as of Q1 2020.

  • Oakbrook Investments held 1,992 shares of CME Group worth $344K as of Q1 2020.
  • Oakbrook Investments sold 5,483 CME Group shares in Q1 2020, an estimated $1.09M.
  • CME Group made up 0.88% of Oakbrook Investments's portfolio in Q1 2020, its #44 holding.
  • Oakbrook Investments first reported a position in CME Group in Q2 2013 and has held it in 28 quarters since.
  • Oakbrook Investments's CME Group position peaked at $41.7M in Q3 2019.
  • 1,030 funds tracked by Wall St. Rank held CME Group as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.